SubHero Banner
Text

3rd Quarter 2021

Key topics in this quarter’s edition include:

  • Saphnelo (anifrolumab) for treatment of systemic lupus erythematosus
  • Bimekizumab for the treatment of plaque psoriasis
  • Plinabulin for prevention of chemotherapy-induced neutropenia
  • Efgartigimod for the treatment of myasthenia gravis

Download PDF

Text